Press Announcements > Statement from FDA Commissioner Scott Gottlieb, M.D., on the signing of the Right to Try Act

Press Announcements > Statement from FDA Commissioner Scott Gottlieb, M.D., on the signing of the Right to Try Act

Statement from FDA Commissioner Scott Gottlieb, M.D., on the signing of the Right to Try Act

For patients with serious or immediately life-threatening diseases, the FDA remains committed to enhancing access to promising investigational medicines for those unable to access products through clinical trials. This is the mission of our expanded access program. The agency is dedicated to these purposes, and it has been for more than three decades. 

Continue reading...